AAAAAA

   
Results: 1-23 |
Results: 23
Inhibition of HIV-1 replication in vitro and in human infected cells by modified antisense oligonucleotides targeting the tRNA(Lys3) /RNA initiation complex
Authors: Freund, F Boulme, F Michel, J Ventura, M Moreau, S Litvak, S
Citation: F. Freund et al., Inhibition of HIV-1 replication in vitro and in human infected cells by modified antisense oligonucleotides targeting the tRNA(Lys3) /RNA initiation complex, ANTISENSE N, 11(5), 2001, pp. 301-315
Initiation of HIV-2 reverse transcription: a secondary structure model of the RNA-tRNA(Lys3) duplex
Authors: Freund, F Boulme, F Litvak, S Tarrago-Litvak, L
Citation: F. Freund et al., Initiation of HIV-2 reverse transcription: a secondary structure model of the RNA-tRNA(Lys3) duplex, NUCL ACID R, 29(13), 2001, pp. 2757-2765
Functional interactions of human immunodeficiency virus type 1 integrase with human and yeast HSP60
Authors: Parissi, V Calmels, C De Soultrait, VR Caumont, A Fournier, M Chaignepain, S Litvak, S
Citation: V. Parissi et al., Functional interactions of human immunodeficiency virus type 1 integrase with human and yeast HSP60, J VIROLOGY, 75(23), 2001, pp. 11344-11353
HCV RNA-dependent RNA polymerase replicates in vitro the 3 ' terminal region of the minus-strand viral RNA more efficiently than the 3 ' terminal region of the plus RNA
Authors: Reigadas, S Ventura, M Sarih-Cottin, L Castroviejo, M Litvak, S Astier-Gin, T
Citation: S. Reigadas et al., HCV RNA-dependent RNA polymerase replicates in vitro the 3 ' terminal region of the minus-strand viral RNA more efficiently than the 3 ' terminal region of the plus RNA, EUR J BIOCH, 268(22), 2001, pp. 5857-5867
Identification of fifteen novel mutations and genotype-phenotype relationship in Fabry disease
Authors: Altarescu, GM Goldfarb, LG Park, KY Kaneski, C Jeffries, N Litvak, S Nagle, JW Schiffmann, R
Citation: Gm. Altarescu et al., Identification of fifteen novel mutations and genotype-phenotype relationship in Fabry disease, CLIN GENET, 60(1), 2001, pp. 46-51
DNA aptamers selected against the HIV-1 RNase H display in vitro antiviralactivity
Authors: Andreola, ML Pileur, F Calmels, C Ventura, M Tarrago-Litvak, L Toulme, JJ Litvak, S
Citation: Ml. Andreola et al., DNA aptamers selected against the HIV-1 RNase H display in vitro antiviralactivity, BIOCHEM, 40(34), 2001, pp. 10087-10094
Synthesis and evaluation of oligo-1,3-thiazolecarboxamide derivatives as HIV-1 reverse transcriptase inhibitors
Authors: Ryabinin, VA Zakharova, OD Yurchenko, EY Timofeeva, OA Martyanov, IV Tokarev, AA Belanov, EF Bormotov, NI Tarrago-Litvak, L Andreola, ML Litvak, S Nevinsky, GA Sinyakov, AN
Citation: Va. Ryabinin et al., Synthesis and evaluation of oligo-1,3-thiazolecarboxamide derivatives as HIV-1 reverse transcriptase inhibitors, BIO MED CH, 8(5), 2000, pp. 985-993
Inactivation of the SNF5 transcription factor gene abolishes the lethal phenotype induced by the expression of HIV-1 integrase in yeast
Authors: Parissi, V Caumont, A de Soultrait, VR Dupont, CH Pichuantes, S Litvak, S
Citation: V. Parissi et al., Inactivation of the SNF5 transcription factor gene abolishes the lethal phenotype induced by the expression of HIV-1 integrase in yeast, GENE, 247(1-2), 2000, pp. 129-136
Inhibition of HIV-1 integrase-catalysed reaction by new DNA minor groove ligands: the oligo-1,3-thiazolecarboxamide derivatives
Authors: Ryabinin, VA Sinyakov, AN de Soultrait, VR Caumont, A Parissi, V Zakharova, OD Vasyutina, EL Yurchenko, E Bayandin, R Litvak, S Tarrago-Litvak, L Nevinsky, GA
Citation: Va. Ryabinin et al., Inhibition of HIV-1 integrase-catalysed reaction by new DNA minor groove ligands: the oligo-1,3-thiazolecarboxamide derivatives, EUR J MED C, 35(11), 2000, pp. 989-1000
Generation of G-to-A and C-to-U changes in HIV-1 transcripts by RNA editing
Authors: Bourara, K Litvak, S Araya, A
Citation: K. Bourara et al., Generation of G-to-A and C-to-U changes in HIV-1 transcripts by RNA editing, SCIENCE, 289(5484), 2000, pp. 1564-1566
Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae
Authors: Parissi, V Caumont, AB de Soultrait, VR Calmels, C Pichuantes, S Litvak, S Dupont, CH
Citation: V. Parissi et al., Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae, J MOL BIOL, 295(4), 2000, pp. 755-765
Desmin splice variants causing cardiac and skeletal myopathy
Authors: Park, KY Dalakas, MC Goebel, HH Ferrans, VJ Semino-Mora, C Litvak, S Takeda, K Goldfarb, LG
Citation: Ky. Park et al., Desmin splice variants causing cardiac and skeletal myopathy, J MED GENET, 37(11), 2000, pp. 851-857
Study of HIV-2 primer-template initiation complex using antisense oligonucleotides
Authors: Boulme, F Freund, F Gryaznov, S Nielsen, PE Tarrago-Litvak, L Litvak, S
Citation: F. Boulme et al., Study of HIV-2 primer-template initiation complex using antisense oligonucleotides, EUR J BIOCH, 267(9), 2000, pp. 2803-2811
Towards the selection of phosphorothioate aptamers - Optimizing in vitro selection steps with phosphorothioate nucleotides
Authors: Andreola, ML Calmels, C Michel, J Toulme, JJ Litvak, S
Citation: Ml. Andreola et al., Towards the selection of phosphorothioate aptamers - Optimizing in vitro selection steps with phosphorothioate nucleotides, EUR J BIOCH, 267(16), 2000, pp. 5032-5040
Sporadic cardiac and skeletal myopathy caused by a de novo desmin mutation
Authors: Park, KY Dalakas, MC Semino-Mora, C Lee, HS Litvak, S Takeda, K Ferrans, VJ Goldfarb, LG
Citation: Ky. Park et al., Sporadic cardiac and skeletal myopathy caused by a de novo desmin mutation, CLIN GENET, 57(6), 2000, pp. 423-429
Interaction of oligonucleotides conjugated to substituted chromones and coumarins with HIV-1 reverse transcriptase
Authors: Martyanov, IV Zakharova, OD Sottofattori, E Pyshnyi, DV Yurchenko, EY Babbi, P Mazzei, M Balbi, A Andreola, ML Litvak, S Tarrago-Litvak, L Nevinsky, GA
Citation: Iv. Martyanov et al., Interaction of oligonucleotides conjugated to substituted chromones and coumarins with HIV-1 reverse transcriptase, ANTISENSE N, 9(5), 1999, pp. 473-480
Effect of nucleoside analogs and non-nucleoside inhibitors of HIV-1 reverse transcriptase on cell-free virions
Authors: Ventura, M Tarrago-Litvak, L Dolle, V Nguyen, CH Legraverend, M Fleury, HJA Litvak, S
Citation: M. Ventura et al., Effect of nucleoside analogs and non-nucleoside inhibitors of HIV-1 reverse transcriptase on cell-free virions, ARCH VIROL, 144(3), 1999, pp. 513-523
Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA
Authors: Mestre, B Arzumanov, A Singh, M Boulme, F Litvak, S Gait, MJ
Citation: B. Mestre et al., Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA, BBA-GENE ST, 1445(1), 1999, pp. 86-98
Cross-linking localization of a HIV-1 reverse transcriptase peptide involved in the binding of primer tRNA(Lys3)
Authors: Dufour, E Reinbolt, J Castroviejo, N Ehresmann, B Litvak, S Tarrago-Litvak, L Andreola, ML
Citation: E. Dufour et al., Cross-linking localization of a HIV-1 reverse transcriptase peptide involved in the binding of primer tRNA(Lys3), J MOL BIOL, 285(4), 1999, pp. 1339-1346
High affinity interaction of HIV-1 integrase with specific and non-specific single-stranded short oligonucleotides
Authors: Caumont, A Jamieson, G de Soultrait, VR Parissi, V Fournier, M Zakharova, OD Bayandin, R Litvak, S Tarrago-Litvak, L Nevinsky, GA
Citation: A. Caumont et al., High affinity interaction of HIV-1 integrase with specific and non-specific single-stranded short oligonucleotides, FEBS LETTER, 455(1-2), 1999, pp. 154-158
Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease
Authors: Lee, HS Sambuughin, N Cervenakova, L Chapman, J Pocchiari, M Litvak, S Qi, HY Budka, H del Ser, T Furukawa, H Brown, P Gajdusek, DC Long, JC Korczyn, AD Goldfarb, LG
Citation: Hs. Lee et al., Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease, AM J HU GEN, 64(4), 1999, pp. 1063-1070
Interaction of tRNA-derivatives and oligonucleotide primers with AZT-resistant mutants of HIV-1 reverse transcriptase
Authors: Zakharova, OD Suturina, OA Timofeeva, OA Gudima, SO Yamkovoi, VI Kochetkov, SN Fournier, M Tarrago-Litvak, L Litvak, S Nevinsky, GA
Citation: Od. Zakharova et al., Interaction of tRNA-derivatives and oligonucleotide primers with AZT-resistant mutants of HIV-1 reverse transcriptase, BIO MED CH, 6(11), 1998, pp. 2041-2049
Modified (PNA, 2 '-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription
Authors: Boulme, F Freund, F Moreau, S Nielsen, PE Gryaznov, S Toulme, JJ Litvak, S
Citation: F. Boulme et al., Modified (PNA, 2 '-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription, NUCL ACID R, 26(23), 1998, pp. 5492-5500
Risultati: 1-23 |